MobiHealthNews

FDA meeting to weigh whether Dexcom's G5 CGM can replace fingersticks for treatment decisions

Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...
CBS News

FDA OK's new diabetes device that aims to simplify daily testing, dosing

A new diabetes device may make tracking blood sugars and taking medication easier. The U.S. Food and Drug Administration said Tuesday that the Dexcom G5 continuous glucose monitoring system (CGM) can ...
MobiHealthNews

Product recall dings Dexcom's Q2, but hopes are high after FDA panel greenlight

Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s ...
FierceBiotech

FDA approves first self-contained, mobile continuous blood glucose monitor from Dexcom

Sensor (1), transmitter (2), and a smartphone showing glucose data (3) -- Courtesy of Dexcom Dexcom ($DXCM) had put a bit of a Band-Aid on its mobile strategy--its ...
FierceBiotech

DexCom profitable for the first time, completes FDA submission for smartphone glucose monitor

Continuous glucose monitor company DexCom ($DXCM) turned a profit for the first time during the fourth quarter of last year. It also said it completed its FDA ...